Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Other Accumulated Expenses (2017 - 2025)

Neuronetics (STIM) has disclosed Other Accumulated Expenses for 9 consecutive years, with $376000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 64.33% to $376000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $376000.0, a 64.33% decrease, with the full-year FY2024 number at $605000.0, down 42.55% from a year prior.
  • Other Accumulated Expenses was $376000.0 for Q3 2025 at Neuronetics, up from $285000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $1.2 million in Q1 2025 to a low of $285000.0 in Q2 2025.
  • A 5-year average of $778263.2 and a median of $853000.0 in 2023 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: soared 134.86% in 2022, then tumbled 74.55% in 2025.
  • Neuronetics' Other Accumulated Expenses stood at $980000.0 in 2021, then fell by 18.37% to $800000.0 in 2022, then soared by 31.62% to $1.1 million in 2023, then crashed by 42.55% to $605000.0 in 2024, then plummeted by 37.85% to $376000.0 in 2025.
  • Per Business Quant, the three most recent readings for STIM's Other Accumulated Expenses are $376000.0 (Q3 2025), $285000.0 (Q2 2025), and $1.2 million (Q1 2025).